Big Pharma paid $43B for this tech? Is this biotech next?

Could this biotech spark Big Pharma's next multibillion-dollar move?

The $43B Big Pharma Blueprint

Big Pharma once paid $43B to acquire a small biotech with similar technology.

Now, a new company is following that same playbook...backed by patents, data, and early-stage traction.

If history repeats, this could be one of the most interesting biotech stories this year.

Message Disclaimer
This is a paid placement email where Sandpiper Marketing Group, LLC is being compensated by i2i Media Group, LLC up to three dollars per click and may exceed three thousand dollars per week (defined as Monday through Friday when the email was sent) for placement of specific advertisements contained in this email newsletter. Sandpiper Marketing Group, LLC and its principles have not evaluated or researched this content and do not own any of the securities mentioned in this email or in the article that this email links to. Please see the disclaimer on the advertiser’s website for additional information, including their relationship with any mentioned security.